Panacea Biotec Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 1,731.7 million compared to INR 1,433.4 million a year ago. Net loss was INR 541.4 million compared to INR 697 million a year ago. Basic loss per share from continuing operations was INR 8.84 compared to INR 11.17 a year ago. For the full year, total revenue was INR 6,347.9 million compared to INR 5,737.5 million a year ago. Net loss was INR 1,476.5 million compared to INR 1,942.9 million a year ago. Basic loss per share from continuing operations was INR 23.87 compared to INR 30.67 a year ago.